Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Gynecologic 1Genitourinary 1Gastrointestinal 1Dermatologic 1

Conditions

Lung Neoplasms 4Small Cell Lung Carcinoma 3Carcinoma, Non-Small-Cell Lung 3Uterine Cervical Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Penile Neoplasms 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

pembrolizumab 4Nivolumab 4Ipilimumab 2Interleukin-2 2Drug Therapy 2Biopsy 2poly ICLC 1pertuzumab 1osimertinib 1montanide ISA 51 1liposomal doxorubicin 1cobimetinib 1cemiplimab 1cc-486 1brodalumab 1atezolizumab 1Trastuzumab 1Tissue Banks 1Standard of Care 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Poly I-C 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Skin Neoplasms × Isotretinoin × Thoracic × Clear all
NCT00002506 2011-05-12

Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Hoag Memorial Hospital Presbyterian

Phase 2 Completed
DermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Penile Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡